$4 generic antidepressant significantly reduces COVID-19 hospitalizations, clinical trial finds
An inexpensive, generic antidepressant has been shown to significantly reduce the risk of severe COVID-19 in clinical trials.
Fluvoxamine — a readily available pill used to treat depression and obsessive-compulsive disorder — dramatically reduces serious illness and death from COVID-19 when prescribed early, according to a study published in the journal Lancet Global Health.--
More...
The Blaze -- Bio and
Archives |
Comments
Blaze Media is news and entertainment for people who love America. As one of the nation’s largest independent media companies, Blaze Media reaches over 165 million people each month through radio, podcasts, Roku, Amazon Fire, Apple TV, social media, email newsletters, and the web.